Cancer-linked genes as targets for chemotherapy
CA 2425643 A1 · Owner: Horrigan, Stephen · Inventors: Young, Paul E.; Weaver, Zoe; Horrigan, Stephen
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Cancer-linked gene sequences, and derived amino acid sequences are disclosed , along with processes for assaying potential antitumor agents based on their modulation of the expression of these cancer-linked genes. Also disclosed are antibodies that react with the disclosed polypeptides and methods of diagnosing and treating cancer using the gene sequences. A novel gene and polypeptide are also disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 11, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 11, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 11, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.